Electricity prices are rising faster than inflation, leaving millions of Americans with overdue utility debt and putting ...

Eli Lilly and Company (NYSE: LLY) today announced new exploratory data from the TOGETHER-PsO Phase 3b clinical trial evaluating the ...

While the Dreamcast wasn't the forever home for the JRPG genre, it certainly tried to revolutionize it with what it had.

According to the Ministry of Public Security, people can create digital signatures directly on VNeID for free quickly and ...

Windows 11's Advanced Shader Delivery is now self-service for developers. We explain how SODB and PSDB differ, the two ways ...

Tigard residents will soon weigh in on multiple candidates running for seats on the city council. Eight people filed for ...

With its blazingly white beaches, dynamic arts scene and idyllic Gulf islands, the Bradenton Area is a destination waiting to be discovered ...

UCB, a global biopharmaceutical company, today announced the launch of Wear It Out, a program created with and for people living with hidradenitis suppurativa (HS), plaque psoriasis (PSO), and ...

Johnson & Johnson (NYSE: JNJ) today announced new two-year results from the Phase 3 ICONIC-LEADa study evaluating ICOTYDE® (icotrokinra), the first and only targeted oral peptide that precisely blocks ...

ZORYVE growth drives profit shift, raises FY2026 sales guide, and has strong cash flow & EPS outlook. Click for more on ARQT ...

Our Fire Emblem: Fortune's Weave beginner's guide includes essential tips and tricks to help you start on the right foot ...

Yvette C. Terrie, BSPharm, discusses new recommendations for treating psoriasis and atopic dermatitis using biologic and oral targeted therapies.